MPWT
ORKA

MassMutual Private Wealth & Trust’s Oruka Therapeutics ORKA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286 Buy
+3
New +$200 ﹤0.01% 2335

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MassMutual Private Wealth & Trust's ORKA Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 3 shares worth $286. The stake represents ﹤0.01% of the portfolio and ranks #2335 among its holdings.

255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • MassMutual Private Wealth & Trust held 3 shares of Oruka Therapeutics worth $286 as of Q2 2026.
  • Oruka Therapeutics was a new MassMutual Private Wealth & Trust position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2335 holding.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.